Quality of Care for Type 2 Diabetes Mellitus in Tripoli Medical Center: a retrospective study of 628 patients
DOI:
https://doi.org/10.54361/Keywords:
Glycemic Control, Diabetes Type 2, Libya, TMC, targets, standards, quality of care, Tertiary careAbstract
Introduction: Diabetes mellitus (DM) is a major public health problem. Evidence has shown that aggressive control of hyperglycemia and associated risk factors reduces the risk of both macro vascular and micro vascular complications. Objectives: The aim of this study was to determine the proportion of diabetes patients reaching the targets recommended by The American Diabetes Association (ADA) standards for diabetes care. Methods and Materials: This is a retrospective study, conducted at the diabetes outpatient clinics at TMC. For 628 patients with diabetes with at least two clinic visits in the 24 months before August 2010, we assessed measurement and control of HbA1c, blood pressure, and lipid, the data were collected in a specially designed data sheet, and analyzed using SPSS program. Results: 628 patients were studied. The mean age was 49.6±11.8years; average duration of diabetes was 6.5±5.0years; The mean last HbA1c was 8.2±2.4%. 75.1%attained a systolic blood pressure of <140 and 75.7%attained a diastolic blood pressure of <90 mmHg. Only 30.8%had LDL cholesterol of < 100 mg/dl & 49.0%had a triglyceride level of < 150 mg/dl. The rate of annual foot examination, retinal examination screening, and urine micro albumin screening were low Conclusions: This study demonstrates a low rate of diabetes care targets achievement among patients with type 2 diabetes treated at TMC.
Downloads
References
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE (2014). Global estimates of diabetes prevalence for 2013 and projections for 2035, Diabetes Res Clin Pract 103(2):137-49.
International diabetes federation (IDF) (2013) IDF Diabetes atlas. edn.6, International diabetes federation, Brussels, Belgium, Europe.
Kadiki OA, Roaeid RB (2001) Prevalence of diabetes mellitus and impaired glucose tolerance in Benghazi Libya, Diabetes Metab 27(6), 647–654.
World Health Organization (2012) STEPwise surveillance of noncommunicable disease risk factors in the Eastern Mediterranean region, Available at: http://bit.ly/126n6Z1 (accessed 7.6.2013).
Stratton IM, Adler AI, Neil HA, et al(2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, BMJ 321,405–12.
Forbes JM, Cooper ME (2013) Mechanisms of diabetic complications, Physiol Rev 93(1), 137-88.
Brown JB, Pedula KL, Bakst AW(1999) The progressive cost of complications in type 2 diabetes mellitus, Arch Intern Med 159,1873–1880
da Rocha Fernandes J, Ogurtsova K, Linnenkamp U, et al(2016) IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes, Diabetes Res Clin Pract 117,48– 54.
Seuring T, Archangelidi O, Suhrcke M(2015) The economic costs of type 2 diabetes: a global systematic review, Pharmacoeconomics 33, 811–311.
American Diabetes Association (2013) Economic costs of diabetes in the U.S. in 2012, Diabetes Care 36,1033–46.
Preis SR, Pencina MJ, Hwang SJ, et al(2009) Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study, Circulation 120(3), 212–220.
Lorber D(2014) Importance of cardiovascular disease and risk management in patients with type 2 diabetes mellitus, Diabetes Metab Syndrome Obes 7, 169–183.
The Diabetes Control and Complications Trial Research Group(1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med 329, 977-986.
UK Prospective Diabetes Study (UKPDS) Group(1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet 352, 837-853.
UK Prospective Diabetes Study (UKPDS) Group(1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: 38, BMJ 317, 703-713.
Costa J, Borges M, David C, Carneiro AV(2006) Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials, BMJ 332, 1115-1124.
S. M. Marshal and A. Flybjerg(2006) “Prevention and early detection of vascular complications of diabetes”, BMJ 333, 475–480.
Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM (1998) Preventive foot care in people with diabetes, Diabetes Care 21(12), 2161–2177
Gross JL, De Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T(2005) Diabetic nephropathy: diagnosis, prevention, and treatment, Diabetes Care 28,164-176.
Bragge P, Gruen RL, Chau M, Forbes A, Taylor HR(2011) Screening for presence or absence of diabetic retinopathy: a meta-analysis, Arch Ophthalmol 129, 435–444
American Diabetes Association (2017) American Diabetes Association Standards of Medical Care in Diabetes – 2017, Diabetes Care 40 (sup 1),S1-S138
Grant RW, Buse JB, Meigs JB(2005) Quality of Diabetes Care in U.S. Academic Medical Centers: Low rates of medical regimen change, Diabetes Care 28,337–442
Cooper JG , C laudi T , J enum AK , T hue G , H ausken MF , Ingskog W , et al (2009) Quality of care for patients with type 2 diabetes in primary care in Norway is improving: Results of cross-sectional surveys of 33 general practices in 1995 and 2005, Diabetes Care 32 , 81 – 3
Laxy, M., Knoll, G., Schunk, M., Meisinger, C., Huth, C. and Holle, R. (2016) Quality of Diabetes Care in Germany Improved from 2000 to 2007 to 2014, But Improvements Diminished since 2007. Evidence from the Population-Based KORA Studies, PLoS ONE 11(10), e0164704.
Alhyas L, McKay A, Balasanthiran A, Majeed A(2011) Quality of type 2 diabetes management in the states of the Co-operation Council for the Arab States of the Gulf: a systematic review, PLoS One 6(8), e22186.
Cagliero E, Levina EV, Nathan DM(1999) Immediate feedback of HbA1c levels improves glycemic control in type 1 and type 2 diabetic patients, Diabetes Care 11,1785.
Larsen ML, Hørder M, Mogensen EF(1990) Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus, N Engl J Med 323, 1021–5.
Yang S, Kong W, Hsue C, Fish AF, Chen Y, Guo X, et al (2016) Knowledge of A1c Predicts Diabetes Self-Management and A1c Level among Chinese Patients with Type 2 Diabetes, PLoS ONE 11(3), e0150753.
Badawi D, Saleh S, Natafgi N, Mourad Y, Behbehani K(2015) Quality of type II diabetes care in primary health care centers in Kuwait: employment of a diabetes quality indicator set (DQIS), PLoS One. 10(7), e0132883.
Akel M, Hamadeh G(1999) Quality of diabetes care in a university health centre in Lebanon, Int J Qual Health Care 11, 517-21.
Kharal M, Al-Hajjaj A, Al-Ammri M, Al-Mardawi G, Tamim HM, Salih SB, et al(2010) Meeting the American Diabetic Association standards of diabetic care, Saudi J Kidney Dis Transpl 21(4), 678-685.
Al-Elq, A.H. (2009) Current Practice in the Management of Patients with Type 2 Diabetes Mellitus in Saudi Arabia, Saudi Medical Journal30, 1551-1556.
Alhyas L, Cai Y, Majeed A(2012) Type 2 diabetes care for patients in a tertiary care setting in UAE: a retrospective cohort study, JRSM Short Rep 3(10), 67.
Al-Hussein, FA(2007) Diabetes control in a primary care setting: a retrospective study of 651 patients, Ann Saudi Med 28(4),267–271.
Saydah SH, Fradkin J, Cowie CC(2004) Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes, JAMA 291(3), 335-42.
Turner RC, Cull CA, Frighi V, Holman RR(1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group, JAMA 281, 2005-2012
Schmittdiel JA, Uratsu CS, Karter AJ, Heisier M, Subramanian U, Mangione CM et al(2008) Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification, J Gen Intern Med 23, 588-594.
TRIAD Study Group (2010) Health systems, patient factors, and quality of care for diabetes: a synthesis of findings from the TRIAD study, Diabetes Care 33 (4), 940–947.
Beaton SJ, Nag SS, Gunter MJ, Gleeson JM, Sajjan SS, Alexander CM(2004) Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting, Diabetes Care 27,694–698.
UK Prospective Diabetes Study Group(1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38, BMJ 317, 703-13.
ACCORD Study Group, Cushman WC, Evans GW, et al(2010) Effects of intensive blood-pressure control in type 2 diabetes mellitus, N Engl J Med 362 (17),1575–1585
Al-Mandhari A, Al-Zakwani I, El-Shafie O, Al-Shafaee M, Woodhouse N(2009) Quality of diabetes care: A cross-sectional observational study in Oman, Sultan Qaboos Univ Med J 9(1), 32-6.
Downloads
Published
Issue
Section
License
Copyright (c) 2017 Dr. Hawa Juma ElShareif (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
